Dr Alison Oliver has spoken out after a lifeline drug has been blocked by health bosses.
Epcoritamab can now be accessed as an option to treat relapsed or refractory follicular lymphoma in adults after 2 or more lines of systemic treatment, only if epcoritamab is stopped after 3 years of ...